Literature DB >> 22409562

Ocular involvement in hospitalized patients with candidemia: analysis at a Boston tertiary care center.

Nancy Huynh1, Han-Ying Peggy Chang, Sheila Borboli-Gerogiannis.   

Abstract

PURPOSE: To study the prevalence, microbial profile, and risk factors for ocular involvement in patients with candidemia.
METHODS: The records of all inpatient consultations requested at the Brigham and Women's Hospital from October 2009 to June 2011 to evaluate for ocular involvement in patients with candidemia were retrospectively reviewed.
RESULTS: Forty-nine consults were requested to rule out ocular involvement in patients with candidemia. The mean patient age was 55 years. In decreasing frequency, the organisms isolated were Candida albicans (42%), Candida parapsilosis (23%), Candida glabrata (17%), Candida tropicalis (8%), Candida dublinensis (5%), Candida krusei (3%), and Candida lusitaniae (3%). All patients were on antifungal treatment at the time of their initial ophthalmologic examination. One patient had evidence of chorioretinitis, and 3 patients had nonspecific fundus findings. Common risk factors included presence of an intravenous catheter, malignancy, and abdominal surgery.
CONCLUSIONS: Ocular involvement is rare among patients with systemic Candida infection.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22409562     DOI: 10.3109/09273948.2011.646383

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  9 in total

1.  Calcineurin controls hyphal growth, virulence, and drug tolerance of Candida tropicalis.

Authors:  Ying-Lien Chen; Shang-Jie Yu; Hsin-Yu Huang; Ya-Lin Chang; Virginia N Lehman; Fitz Gerald S Silao; Ursela G Bigol; Alice Alma C Bungay; Anna Averette; Joseph Heitman
Journal:  Eukaryot Cell       Date:  2014-01-17

2.  Outcomes, impact on management, and costs of fungal eye disease consults in a tertiary care setting.

Authors:  Devon H Ghodasra; Kian Eftekhari; Ankoor R Shah; Brian L VanderBeek
Journal:  Ophthalmology       Date:  2014-08-10       Impact factor: 12.079

3.  The Incidence of Ocular Complications in Candidemic Patients and Implications for the Practice of Routine 
Eye Exams.

Authors:  Molly Hillenbrand; Angelico Mendy; Kavya Patel; Racheal Wilkinson; Siyun Liao; Jamie Robertson; Senu Apewokin
Journal:  Open Forum Infect Dis       Date:  2022-03-19       Impact factor: 3.835

Review 4.  Candida lusitaniae: Biology, Pathogenicity, Virulence Factors, Diagnosis, and Treatment.

Authors:  Manuela Gómez-Gaviria; Héctor M Mora-Montes; Diana F Mendoza-Reyes
Journal:  Infect Drug Resist       Date:  2022-08-31       Impact factor: 4.177

5.  Pharmacokinetics and pharmacodynamics of anidulafungin for experimental Candida endophthalmitis: insights into the utility of echinocandins for treatment of a potentially sight-threatening infection.

Authors:  J L Livermore; T W Felton; J Abbott; A Sharp; J Goodwin; L Gregson; P A Warn; S J Howard; W W Hope
Journal:  Antimicrob Agents Chemother       Date:  2012-10-31       Impact factor: 5.191

6.  Incidence of chorioretinitis and endophthalmitis in hospitalized patients with fungemia.

Authors:  Mohammad Z Siddiqui; Grant M Gebhard; Kinza T Ahmad; Ahmed B Sallam; Eric R Rosenbaum; Sami H Uwaydat
Journal:  Eye (Lond)       Date:  2021-03-08       Impact factor: 3.775

7.  Calcineurin is required for pseudohyphal growth, virulence, and drug resistance in Candida lusitaniae.

Authors:  Jing Zhang; Fitz Gerald S Silao; Ursela G Bigol; Alice Alma C Bungay; Marilou G Nicolas; Joseph Heitman; Ying-Lien Chen
Journal:  PLoS One       Date:  2012-08-31       Impact factor: 3.240

8.  Prevalence and factors predictive of intraocular fungal infection in patients with fungemia at an academic urban tertiary care center.

Authors:  Elena Geraymovych; Joseph H Conduff; Puneet S Braich; Christopher T Leffler; Vikram S Brar
Journal:  Clin Ophthalmol       Date:  2015-09-29

9.  Text Processing for Detection of Fungal Ocular Involvement in Critical Care Patients: Cross-Sectional Study.

Authors:  Sally L Baxter; Adam R Klie; Bharanidharan Radha Saseendrakumar; Gordon Y Ye; Michael Hogarth
Journal:  J Med Internet Res       Date:  2020-08-14       Impact factor: 5.428

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.